Tanalys

Integrum appoints Chief Operating Officer

Mölndal, Sweden, January 26, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has appointed Mats Dotevall to the newly established position as Chief Operating Officer (COO) and site manager. Mats Dotevall will join the company on February 1, 2023, and will be part of the management team

Mats Dotevall has over 30 years of experience in management, product development, and business development within the medtech industry. Former positions include senior management roles at GN ReSound in the US and Europe and Director of Design and Development at Cochlear Bone Anchored Solutions.

“I am very happy to join Integrum, a company with a strong history and clear purpose to help people with an improved quality of life based on a unique approach of using osseointegration for prostheses. I look forward to being part of an exciting journey ahead, working with a great team through the product’s entire life cycle with very promising opportunities for the future,” says Mats Dotevall”

“As Integrum continues to grow, we need to reinforce our operational excellence continuously. To this end, we are very pleased to welcome Mats Dotevall to the newly established position of COO and site manager. He is a strategic leader with excellent management skills and knows the global implant business very well. Together, we will strive to progress Integrum’s business further by fully leveraging our innovative products and talented employees,” says Rickard Brånemark, CEO of Integrum.

For more information please contact:

Rickard Brånemark, CEO. +46 (0) 70 846 10 61, E-mail: rickard.branemark@integrum.se

Dennis Baecklund, CFO. +46 (0) 72 556 68 69, E-mail: dennis.baecklund@integrum.se

Certified Adviser

Erik Penser Bank is Certified Adviser and can be reached at +46 (0) 8-463 8000.

Integrum AB is a publicly traded company (INTEG B: Nasdaq First North Growth Market) based outside of Gothenburg, Sweden, with a US subsidiary in San Francisco, CA. Since 1990, osseointegration, the science behind the OPRA™ Implant System, has been helping individuals with amputations enjoy a dramatically improved quality of life. Thorough surgical experience gained over more than three decades, from more than 500 surgeries, in 14 countries, has led to the development of Integrum’s system for bone-anchored prostheses – a vastly superior alternative to the traditionally used socket prosthesis.

Exit mobile version